Author Correction: Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature

doi:10.1038/s41582-020-0392-9

Published Erratum

. 2021 Apr;17(4):260.

doi: 10.1038/s41582-020-0392-9.

Author Correction: Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature

Catharina Korsukewitz¹, Stephen W Reddel², Amit Bar-Or³, Heinz Wiendl⁴

Affiliations

¹ Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany.
² Department of Neurology, Concord Hospital and The Brain and Mind Centre, University of Sydney, Sydney, Australia.
³ Center for Neuroinflammation and Neurotherapeutics and the Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
⁴ Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany. wiendl@uni-muenster.de.

PMID: 32699330
PMCID: PMC7375453
DOI: 10.1038/s41582-020-0392-9

Published Erratum

Author Correction: Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature

Catharina Korsukewitz et al. Nat Rev Neurol. 2021 Apr.

. 2021 Apr;17(4):260.

doi: 10.1038/s41582-020-0392-9.

Authors

Catharina Korsukewitz¹, Stephen W Reddel², Amit Bar-Or³, Heinz Wiendl⁴

Affiliations

¹ Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany.
² Department of Neurology, Concord Hospital and The Brain and Mind Centre, University of Sydney, Sydney, Australia.
³ Center for Neuroinflammation and Neurotherapeutics and the Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
⁴ Department of Neurology with Institute of Translational Neurology, University of Muenster, Muenster, Germany. wiendl@uni-muenster.de.

PMID: 32699330
PMCID: PMC7375453
DOI: 10.1038/s41582-020-0392-9

No abstract available

PubMed Disclaimer

Erratum for

Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature.
Korsukewitz C, Reddel SW, Bar-Or A, Wiendl H. Korsukewitz C, et al. Nat Rev Neurol. 2020 Sep;16(9):493-505. doi: 10.1038/s41582-020-0385-8. Epub 2020 Jul 8. Nat Rev Neurol. 2020. PMID: 32641860 Free PMC article. Review.

Similar articles

Immunotherapies and COVID-19 related Neurological manifestations: A Comprehensive Review Article.
Anwar MM. Anwar MM. J Immunoassay Immunochem. 2020 Nov 1;41(6):960-975. doi: 10.1080/15321819.2020.1865400. Epub 2021 Jan 3. J Immunoassay Immunochem. 2020. PMID: 33393415 Review.
Author Correction: Caring for patients with cancer in the COVID-19 era.
van de Haar J, Hoes LR, Coles CE, Seamon K, Fröhling S, Jäger D, Valenza F, de Braud F, De Petris L, Bergh J, Ernberg I, Besse B, Barlesi F, Garralda E, Piris-Giménez A, Baumann M, Apolone G, Soria JC, Tabernero J, Caldas C, Voest EE. van de Haar J, et al. Nat Med. 2020 Jul;26(7):1146. doi: 10.1038/s41591-020-0948-7. Nat Med. 2020. PMID: 32494062 Free PMC article.
Recovery of endoscopy services in the era of COVID-19: recommendations from an international Delphi consensus.
Bhandari P, Subramaniam S, Bourke MJ, Alkandari A, Chiu PWY, Brown JF, Keswani RN, Bisschops R, Hassan C, Raju GS, Muthusamy VR, Sethi A, May GR, Albéniz E, Bruno M, Kaminski MF, Alkhatry M, Almadi M, Ibrahim M, Emura F, Moura E, Navarrete C, Wulfson A, Khor C, Ponnudurai R, Inoue H, Saito Y, Yahagi N, Kashin S, Nikonov E, Yu H, Maydeo AP, Reddy DN, Wallace MB, Pochapin MB, Rösch T, Sharma P, Repici A. Bhandari P, et al. Gut. 2020 Nov;69(11):1915-1924. doi: 10.1136/gutjnl-2020-322329. Epub 2020 Aug 14. Gut. 2020. PMID: 32816921 Review.
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
Pala L, Conforti F, Saponara M, De Pas T, Giugliano F, Omodeo Salè E, Jemos C, Rubatto M, Agostini A, Quaglino P, Fava P, Fierro MT, Queirolo P. Pala L, et al. Semin Oncol. 2020 Oct;47(5):302-304. doi: 10.1053/j.seminoncol.2020.07.010. Epub 2020 Aug 7. Semin Oncol. 2020. PMID: 32883537 Free PMC article.
Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
Walle T, Bajaj S, Kraske JA, Rösner T, Cussigh CS, Kälber KA, Müller LJ, Strobel SB, Burghaus J, Kallenberger SM, Stein-Thöringer CK, Jenzer M, Schubert A, Kahle S, Williams A, Hoyler B, Zielske L, Skatula R, Sawall S, Leber MF, Kunes RZ, Krisam J, Fremd C, Schneeweiss A, Krauss J, Apostolidis L, Berger AK, Haag GM, Zschäbitz S, Halama N, Springfeld C, Kirsten R, Hassel JC, Jäger D; NCT ANTICIPATE Investigators; Ungerechts G. Walle T, et al. Nat Cancer. 2022 Sep;3(9):1137. doi: 10.1038/s43018-022-00420-y. Nat Cancer. 2022. PMID: 35840692 Free PMC article. No abstract available.

See all similar articles

Cited by

COVID-19 in ocrelizumab-treated people with multiple sclerosis.
Hughes R, Whitley L, Fitovski K, Schneble HM, Muros E, Sauter A, Craveiro L, Dillon P, Bonati U, Jessop N, Pedotti R, Koendgen H. Hughes R, et al. Mult Scler Relat Disord. 2021 Apr;49:102725. doi: 10.1016/j.msard.2020.102725. Epub 2020 Dec 30. Mult Scler Relat Disord. 2021. PMID: 33482590 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Author Correction: Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature

Affiliations

Author Correction: Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature

Authors

Affiliations

Erratum for

Similar articles

Cited by

Publication types

LinkOut - more resources

Full Text Sources